Literature DB >> 2308902

Class III antiarrhythmic action linked with positive inotropy: acute electrophysiological and inotropic effects of amiodarone in vitro.

P M Tande1, H Refsum.   

Abstract

Negative inotropy is an adverse feature of most antiarrhythmic drugs. Positive inotropy, however, has been demonstrated for some drugs with class III antiarrhythmic action. Although amiodarone exerts its antiarrhythmic effect by an interplay of different actions on cardiac cells, it has been regarded to be the prototype class III drug due to its prolongation of action potential duration. The present study was designed to test the hypothesis that class III antiarrhythmic action and positive inotropy may be linked. We compared the effects of amiodarone in Cordarone and its solvent Tween 80 on automaticity, refractoriness and inotropy. Two series of experiments were done; one with spontaneously beating rat atria to study the effects on sinus node function, and one with electrically stimulated left atria to study the effects on excitability, refractoriness and inotropy. Amiodarone 1 x 10(-4) M decreased spontaneous heart rate by 13% and prolonged sinus node recovery time by 105%. Without affecting the excitability amiodarone prolonged the effective refractory period by 12%. At the same time contractile force increased by 12%. Lower concentration of amiodarone (5 x 10(-6) M) or Tween 80 had no significant effects. In conclusion, amiodarone exerts acute electrophysiological and inotropic effects in vitro. The class III antiarrhythmic action of amiodarone is linked with positive inotropy.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2308902     DOI: 10.1111/j.1600-0773.1990.tb00694.x

Source DB:  PubMed          Journal:  Pharmacol Toxicol        ISSN: 0901-9928


  5 in total

1.  Na+-K+ pump inhibition caused by chronic amiodarone in guinea pig myocardium.

Authors:  T Maruyama; N Ueda; Y Kaji; S Kanaya; T Fujino; Y Niho
Journal:  Heart Vessels       Date:  1999       Impact factor: 2.037

Review 2.  Physiologic, Pathologic, and Therapeutic Paracrine Modulation of Cardiac Excitation-Contraction Coupling.

Authors:  Joshua Mayourian; Delaine K Ceholski; David M Gonzalez; Timothy J Cashman; Susmita Sahoo; Roger J Hajjar; Kevin D Costa
Journal:  Circ Res       Date:  2018-01-05       Impact factor: 17.367

3.  Negative chronotropic effect of a novel class III antiarrhythmic drug, UK-68,798, devoid of beta-blocking action on isolated guinea-pig atria.

Authors:  T Yang; P M Tande; H Refsum
Journal:  Br J Pharmacol       Date:  1991-06       Impact factor: 8.739

4.  In-silico human electro-mechanical ventricular modelling and simulation for drug-induced pro-arrhythmia and inotropic risk assessment.

Authors:  Francesca Margara; Zhinuo J Wang; Francesc Levrero-Florencio; Alfonso Santiago; Mariano Vázquez; Alfonso Bueno-Orovio; Blanca Rodriguez
Journal:  Prog Biophys Mol Biol       Date:  2020-07-22       Impact factor: 3.667

5.  Risk factors for recurrence of atrial fibrillation in horses after cardioversion to sinus rhythm.

Authors:  A Decloedt; C C Schwarzwald; D De Clercq; N Van Der Vekens; B Pardon; V B Reef; G van Loon
Journal:  J Vet Intern Med       Date:  2015-04-27       Impact factor: 3.333

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.